Health
Targeted drug shows promising activity in kidney cancer patients with brain metastases – News-Medical.Net
A targeted drug has shown promising activity against brain metastases resulting from kidney cancer, achieving a 50 percent response…
A targeted drug has shown promising activity against brain metastases resulting from kidney cancer, achieving a 50 percent response rate, and supporting further studies of the drug in this patient group whose poor prognosis has created a significant unmet…
Continue Reading